1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Benign Prostatic Hyperplasia Devices Revenue
1.4 Market Analysis by Type
1.4.1 Global Benign Prostatic Hyperplasia Devices Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Transurethral Resection of the Prostate (TURP)
1.4.3 Transurethral Microwave Therapy (TUMT)
1.4.4 Transurethral Needle Ablation of the Prostate (TUNA)
1.4.5 Laser Surgery
1.4.6 Prostatic Stenting
1.4.7 Others
1.5 Market by Application
1.5.1 Global Benign Prostatic Hyperplasia Devices Market Share by Application: 2021-2026
1.5.2 Hospitals and Clinics
1.5.3 Ambulatory Surgical Centers(ASC)
1.5.4 Home
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Benign Prostatic Hyperplasia Devices Market
1.8.1 Global Benign Prostatic Hyperplasia Devices Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Benign Prostatic Hyperplasia Devices Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Benign Prostatic Hyperplasia Devices Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Benign Prostatic Hyperplasia Devices Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Benign Prostatic Hyperplasia Devices Sales Volume Market Share by Region (2015-2020)
3.2 Global Benign Prostatic Hyperplasia Devices Sales Revenue Market Share by Region (2015-2020)
3.3 North America Benign Prostatic Hyperplasia Devices Sales Volume
3.3.1 North America Benign Prostatic Hyperplasia Devices Sales Volume Growth Rate (2015-2020)
3.3.2 North America Benign Prostatic Hyperplasia Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Benign Prostatic Hyperplasia Devices Sales Volume
3.4.1 East Asia Benign Prostatic Hyperplasia Devices Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Benign Prostatic Hyperplasia Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Benign Prostatic Hyperplasia Devices Sales Volume (2015-2020)
3.5.1 Europe Benign Prostatic Hyperplasia Devices Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Benign Prostatic Hyperplasia Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Benign Prostatic Hyperplasia Devices Sales Volume (2015-2020)
3.6.1 South Asia Benign Prostatic Hyperplasia Devices Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Benign Prostatic Hyperplasia Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Benign Prostatic Hyperplasia Devices Sales Volume (2015-2020)
3.7.1 Southeast Asia Benign Prostatic Hyperplasia Devices Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Benign Prostatic Hyperplasia Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Benign Prostatic Hyperplasia Devices Sales Volume (2015-2020)
3.8.1 Middle East Benign Prostatic Hyperplasia Devices Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Benign Prostatic Hyperplasia Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Benign Prostatic Hyperplasia Devices Sales Volume (2015-2020)
3.9.1 Africa Benign Prostatic Hyperplasia Devices Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Benign Prostatic Hyperplasia Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Benign Prostatic Hyperplasia Devices Sales Volume (2015-2020)
3.10.1 Oceania Benign Prostatic Hyperplasia Devices Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Benign Prostatic Hyperplasia Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Benign Prostatic Hyperplasia Devices Sales Volume (2015-2020)
3.11.1 South America Benign Prostatic Hyperplasia Devices Sales Volume Growth Rate (2015-2020)
3.11.2 South America Benign Prostatic Hyperplasia Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Benign Prostatic Hyperplasia Devices Sales Volume (2015-2020)
3.12.1 Rest of the World Benign Prostatic Hyperplasia Devices Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Benign Prostatic Hyperplasia Devices Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Benign Prostatic Hyperplasia Devices Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Benign Prostatic Hyperplasia Devices Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Benign Prostatic Hyperplasia Devices Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Benign Prostatic Hyperplasia Devices Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Benign Prostatic Hyperplasia Devices Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Benign Prostatic Hyperplasia Devices Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Benign Prostatic Hyperplasia Devices Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Benign Prostatic Hyperplasia Devices Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Benign Prostatic Hyperplasia Devices Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Benign Prostatic Hyperplasia Devices Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Benign Prostatic Hyperplasia Devices Sales Volume Market Share by Type (2015-2020)
14.2 Global Benign Prostatic Hyperplasia Devices Sales Revenue Market Share by Type (2015-2020)
14.3 Global Benign Prostatic Hyperplasia Devices Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Benign Prostatic Hyperplasia Devices Consumption Volume by Application (2015-2020)
15.2 Global Benign Prostatic Hyperplasia Devices Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Benign Prostatic Hyperplasia Devices Business
16.1 Lumenis
16.1.1 Lumenis Company Profile
16.1.2 Lumenis Benign Prostatic Hyperplasia Devices Product Specification
16.1.3 Lumenis Benign Prostatic Hyperplasia Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 ProArc Medical LTD
16.2.1 ProArc Medical LTD Company Profile
16.2.2 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Product Specification
16.2.3 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Boston Scientific corporation
16.3.1 Boston Scientific corporation Company Profile
16.3.2 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Product Specification
16.3.3 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Olympus corporation
16.4.1 Olympus corporation Company Profile
16.4.2 Olympus corporation Benign Prostatic Hyperplasia Devices Product Specification
16.4.3 Olympus corporation Benign Prostatic Hyperplasia Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Neotrac
16.5.1 Neotrac Company Profile
16.5.2 Neotrac Benign Prostatic Hyperplasia Devices Product Specification
16.5.3 Neotrac Benign Prostatic Hyperplasia Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Urologix
16.6.1 Urologix Company Profile
16.6.2 Urologix Benign Prostatic Hyperplasia Devices Product Specification
16.6.3 Urologix Benign Prostatic Hyperplasia Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Medifocus
16.7.1 Medifocus Company Profile
16.7.2 Medifocus Benign Prostatic Hyperplasia Devices Product Specification
16.7.3 Medifocus Benign Prostatic Hyperplasia Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Lisa Laser
16.8.1 Lisa Laser Company Profile
16.8.2 Lisa Laser Benign Prostatic Hyperplasia Devices Product Specification
16.8.3 Lisa Laser Benign Prostatic Hyperplasia Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Urotech GMBH
16.9.1 Urotech GMBH Company Profile
16.9.2 Urotech GMBH Benign Prostatic Hyperplasia Devices Product Specification
16.9.3 Urotech GMBH Benign Prostatic Hyperplasia Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Benign Prostatic Hyperplasia Devices Manufacturing Cost Analysis
17.1 Benign Prostatic Hyperplasia Devices Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia Devices
17.4 Benign Prostatic Hyperplasia Devices Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Benign Prostatic Hyperplasia Devices Distributors List
18.3 Benign Prostatic Hyperplasia Devices Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Benign Prostatic Hyperplasia Devices (2021-2026)
20.2 Global Forecasted Revenue of Benign Prostatic Hyperplasia Devices (2021-2026)
20.3 Global Forecasted Price of Benign Prostatic Hyperplasia Devices (2015-2026)
20.4 Global Forecasted Production of Benign Prostatic Hyperplasia Devices by Region (2021-2026)
20.4.1 North America Benign Prostatic Hyperplasia Devices Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Benign Prostatic Hyperplasia Devices Production, Revenue Forecast (2021-2026)
20.4.3 Europe Benign Prostatic Hyperplasia Devices Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Benign Prostatic Hyperplasia Devices Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Benign Prostatic Hyperplasia Devices Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Benign Prostatic Hyperplasia Devices Production, Revenue Forecast (2021-2026)
20.4.7 Africa Benign Prostatic Hyperplasia Devices Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Benign Prostatic Hyperplasia Devices Production, Revenue Forecast (2021-2026)
20.4.9 South America Benign Prostatic Hyperplasia Devices Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Benign Prostatic Hyperplasia Devices Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Benign Prostatic Hyperplasia Devices by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Benign Prostatic Hyperplasia Devices by Country
21.2 East Asia Market Forecasted Consumption of Benign Prostatic Hyperplasia Devices by Country
21.3 Europe Market Forecasted Consumption of Benign Prostatic Hyperplasia Devices by Countriy
21.4 South Asia Forecasted Consumption of Benign Prostatic Hyperplasia Devices by Country
21.5 Southeast Asia Forecasted Consumption of Benign Prostatic Hyperplasia Devices by Country
21.6 Middle East Forecasted Consumption of Benign Prostatic Hyperplasia Devices by Country
21.7 Africa Forecasted Consumption of Benign Prostatic Hyperplasia Devices by Country
21.8 Oceania Forecasted Consumption of Benign Prostatic Hyperplasia Devices by Country
21.9 South America Forecasted Consumption of Benign Prostatic Hyperplasia Devices by Country
21.10 Rest of the world Forecasted Consumption of Benign Prostatic Hyperplasia Devices by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer